ClinicalTrials.gg

Drug class

Sodium Potassium Chloride Symporter Inhibitors clinical trials

A class of medicines: the studies that test any of its 5 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
209
open now
33
in phase 3
37
first study started
2000

Keep track of what changes. Save the sodium potassium chloride symporter inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Azosemide
1

Studies by the year they started

207 studies that test it; most in 2015 (16)

Studies that test Sodium Potassium Chloride Symporter Inhibitors, by start year
YearStudies
20001
20012
20021
20033
20042
20056
20061
20072
20085
20099
20108
20118
20128
20139
20147
201516
201615
201715
20188
20197
20207
202115
20223
202315
202411
20259
202614

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
49
Phase 2
38
Phase 3
37
Phase 4
53
No phase
39

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 44 · Other 165

Boehringer Ingelheim (8) · Sarfez Pharmaceuticals, Inc. (4) · Assistance Publique - Hôpitaux de Paris (4) · AstraZeneca (3) · Mayo Clinic (3) · Yale University (3) · University of North Carolina, Chapel Hill (3) · University of Palermo (3)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 209

See all 209 studies that test one of the sodium potassium chloride symporter inhibitors →

Codes

What other systems call Sodium Potassium Chloride Symporter Inhibitors · ClinicalTrials.gg INT008863

  • MeSH (NLM) D049994Sodium Potassium Chloride Symporter InhibitorsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.